APLT
Price
$0.32
Change
-$0.06 (-15.79%)
Updated
Jun 27 closing price
Capitalization
48.43M
39 days until earnings call
TRVI
Price
$5.62
Change
-$0.04 (-0.71%)
Updated
Jun 27 closing price
Capitalization
683.04M
39 days until earnings call
Interact to see
Advertisement

APLT vs TRVI

Header iconAPLT vs TRVI Comparison
Open Charts APLT vs TRVIBanner chart's image
Applied Therapeutics
Price$0.32
Change-$0.06 (-15.79%)
Volume$13.33M
Capitalization48.43M
Trevi Therapeutics
Price$5.62
Change-$0.04 (-0.71%)
Volume$2.23M
Capitalization683.04M
APLT vs TRVI Comparison Chart in %
Loading...
APLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APLT vs. TRVI commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLT is a Hold and TRVI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (APLT: $0.32 vs. TRVI: $5.62)
Brand notoriety: APLT and TRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLT: 571% vs. TRVI: 124%
Market capitalization -- APLT: $48.43M vs. TRVI: $683.04M
APLT [@Biotechnology] is valued at $48.43M. TRVI’s [@Biotechnology] market capitalization is $683.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLT’s FA Score shows that 0 FA rating(s) are green whileTRVI’s FA Score has 0 green FA rating(s).

  • APLT’s FA Score: 0 green, 5 red.
  • TRVI’s FA Score: 0 green, 5 red.
According to our system of comparison, TRVI is a better buy in the long-term than APLT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLT’s TA Score shows that 4 TA indicator(s) are bullish while TRVI’s TA Score has 1 bullish TA indicator(s).

  • APLT’s TA Score: 4 bullish, 4 bearish.
  • TRVI’s TA Score: 1 bullish, 6 bearish.
According to our system of comparison, APLT is a better buy in the short-term than TRVI.

Price Growth

APLT (@Biotechnology) experienced а -5.57% price change this week, while TRVI (@Biotechnology) price change was -5.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

APLT is expected to report earnings on Aug 07, 2025.

TRVI is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRVI($683M) has a higher market cap than APLT($48.4M). TRVI YTD gains are higher at: 36.408 vs. APLT (-62.182). TRVI has higher annual earnings (EBITDA): -47.23M vs. APLT (-108.32M). TRVI has more cash in the bank: 103M vs. APLT (50.8M). TRVI has less debt than APLT: TRVI (957K) vs APLT (2.7M). APLT has higher revenues than TRVI: APLT (265K) vs TRVI (0).
APLTTRVIAPLT / TRVI
Capitalization48.4M683M7%
EBITDA-108.32M-47.23M229%
Gain YTD-62.18236.408-171%
P/E RatioN/AN/A-
Revenue265K0-
Total Cash50.8M103M49%
Total Debt2.7M957K282%
FUNDAMENTALS RATINGS
APLT vs TRVI: Fundamental Ratings
APLT
TRVI
OUTLOOK RATING
1..100
762
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
56
Fair valued
PROFIT vs RISK RATING
1..100
10073
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
9447
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APLT's Valuation (53) in the null industry is in the same range as TRVI (56) in the Pharmaceuticals Major industry. This means that APLT’s stock grew similarly to TRVI’s over the last 12 months.

TRVI's Profit vs Risk Rating (73) in the Pharmaceuticals Major industry is in the same range as APLT (100) in the null industry. This means that TRVI’s stock grew similarly to APLT’s over the last 12 months.

TRVI's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as APLT (98) in the null industry. This means that TRVI’s stock grew similarly to APLT’s over the last 12 months.

TRVI's Price Growth Rating (47) in the Pharmaceuticals Major industry is somewhat better than the same rating for APLT (94) in the null industry. This means that TRVI’s stock grew somewhat faster than APLT’s over the last 12 months.

TRVI's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as APLT (100) in the null industry. This means that TRVI’s stock grew similarly to APLT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APLTTRVI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
89%
N/A
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
APLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYEUX116.601.37
+1.19%
Rydex Europe 1.25x Strategy H
FCUCX19.130.21
+1.11%
NYLI PineStone U.S. Equity Class C
OMSCX23.810.15
+0.63%
Invesco Main Street All Cap C
NSBAX63.630.28
+0.44%
Nuveen Dividend Growth A
WLCVX22.090.09
+0.41%
Wilshire Large Company Value Instl

APLT and

Correlation & Price change

A.I.dvisor tells us that APLT and AMGXF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APLT and AMGXF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLT
1D Price
Change %
APLT100%
-14.79%
AMGXF - APLT
32%
Poorly correlated
N/A
COEP - APLT
27%
Poorly correlated
-3.11%
BPMC - APLT
27%
Poorly correlated
-0.03%
EDIT - APLT
25%
Poorly correlated
+7.55%
TRVI - APLT
25%
Poorly correlated
-0.71%
More

TRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRVI has been loosely correlated with PTGX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if TRVI jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRVI
1D Price
Change %
TRVI100%
-0.71%
PTGX - TRVI
44%
Loosely correlated
+0.86%
BIESF - TRVI
42%
Loosely correlated
N/A
MLYS - TRVI
31%
Poorly correlated
-2.07%
GOSS - TRVI
29%
Poorly correlated
-3.85%
XENE - TRVI
28%
Poorly correlated
+0.62%
More